Will Oura's market cap be between $12.5B and $15B at market close on IPO day?

Prediction markets put the probability at 10%: Will Oura's market cap be between $12.5B and $15B at market close on IPO day. Currently, markets see this as unlikely (10% YES).

What’s Happening

Oura, the Finnish health-tracking ring maker, confidentially filed for an initial public offering with the U.S. Securities and Exchange Commission on May 21, 2026, seven months after closing a $900 million Series E round led by Fidelity Management & Research that valued the company at approximately $11 billion. The company reported more than fourfold revenue growth over the past two fiscal years, reinvesting gross profit into product development and clinical research. Oura also stated it is on pace to surpass five million paid members in the second quarter of 2026, a metric that will be closely scrutinized as the company transitions from private to public markets. The confidential filing does not disclose the target share price or valuation range, leaving the market to speculate on whether oura's market cap be between $12.5b and $15b at market close on ipo day, a scenario currently assigned a 10% probability by traders. [MobiHealthNews, May 22]

The $11 billion valuation from October 2025 represented a 120% increase from the company's $5 billion Series D round in November 2024, reflecting surging investor appetite for personalized health technology. Oura competes directly with Apple and Garmin in the wearable health segment, differentiating itself through clinical-grade sleep and recovery metrics. The IPO filing follows a period of aggressive expansion into healthcare partnerships, with the company planning to develop additional FDA-cleared features for the device. Historical precedent suggests that companies entering public markets at valuations above their last private round often face pricing pressure; however, Oura's revenue trajectory — growing more than fourfold in two fiscal years — provides a fundamental counterweight. Whether oura's market cap be between $12.5b and $15b at market close on ipo day depends on the final offer price, which will be determined by institutional demand during the roadshow, expected in late 2026. [PitchBook, Oct 14]

Market participants are weighing several factors that could influence the IPO-day close. The 10% YES probability for the $12.5B–$15B range implies a potential upside of 14% to 36% from the last private valuation, a premium that would require strong public market reception. Key indicators include the broader IPO market's performance in 2026, current interest rate conditions — with the U.S. 10-year Treasury yield at 4.567% — and sector comparables such as Dexcom and Masimo, which trade at price-to-sales multiples between 8x and 12x. Oura's confidential filing means financial details remain under seal until the SEC review process concludes, but the company's disclosed member growth and revenue acceleration suggest a potential offering size that could place its market cap in the target range. The final pricing will also depend on the lock-up structure, insider selling intentions, and the overall risk appetite for health-tech equities in the second half of 2026. [WSJ, May 21]

Traded on Polymarket — $51K Volume

Lower-volume market on Polymarket ($51K). Wider spreads expected — enter with limit orders and be aware of slippage risk. Currently 10c YES.